[1]
|
Carter, S.J., Tattersall, R.S. and Ramanan, A.V. (2019) Macrophage Activation Syndrome in Adults: Recent Advances in Pathophysiology, Diagnosis and Treatment. Rheumatology, 58, 5-17. https://doi.org/10.1093/rheumatology/key006
|
[2]
|
Lehmberg, K., Nichols, K.E., Henter, J.I., et al. (2015) Consensus Recommendations for the Diagnosis and Management of Hemophagocytic Lymphohistiocytosis Associated with Malignancies. Haematologica, 100, 997-1004.
|
[3]
|
Me Nard, F., Besson, C., Rince, P., et al. (2008) Hodgkin Lymphoma-Associated Hemophagocytic Syndrome: A Disorder Strongly Correlated with Epstein-Barr Virus. Clinical Infectious Diseases, 47, 531-534. https://doi.org/10.1086/590152
|
[4]
|
Delavigne, K., BeRard, E., Bertoli, S., et al. (2014) Hemophagocytic Syndrome in Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy. Aematologica, 99, 474-480. https://doi.org/10.3324/haematol.2013.097394
|
[5]
|
Ok, C.Y., Li, L. and Young, K.H. (2015) EBV-Driven B-Cell Lymphoproliferative Disorders: From Biology, Classification and Differential Diagnosis to Clinical Management. Experimental & Molecular Medicine, 47, e132. https://doi.org/10.1038/emm.2014.82
|
[6]
|
Cho, H.S., Park, Y.N., Lyu, C.J., Park, S.M., Oh, S.H., Yang, C.H., Yang, W.I. and Kim, K.Y. (1997) EBV-Elicited Familial Hemophagocytic Lymphohistiocytosis. Yonsei Medical Journal, 38, 245-248. https://doi.org/10.3349/ymj.1997.38.4.245
|
[7]
|
Chuang, H.C., Lay, J.D., Hsieh, W.C. and Su, I.J. (2007) Pathogenesis and Mechanism of Disease Progression from Hemophagocytic Lymphohistiocytosis to Epstein-Barr Virus-Associated Tcell Lymphoma: Nuclear Factor-KB Pathway as a Potential Therapeutic Target. Cancer Science, 98, 1281-1287. https://doi.org/10.1111/j.1349-7006.2007.00549.x
|
[8]
|
Henter, J.I., Elinder, G., Soder, O., et al. (1991) Hypercytokinemia in Familial Hemophagocytic Lymphohistiocytosis. Blood, 78, 2918-2922. https://doi.org/10.1182/blood.V78.11.2918.2918
|
[9]
|
Osugi, Y., Hara, J., Tagawa, S., et al. (1997) Cytokine Production Regulating Th1 and Th2 Cytokines in Hemophagocytic Lymphohistiocytosis. Blood, 89, 4100-4103. https://doi.org/10.1182/blood.V89.11.4100
|
[10]
|
Brisse, E., Wouters, C.H. and Matthys, P. (2016) Advances in the Pathogenesis of Primary and Secondary Haemophagocytic Lymphohistiocytosis: Differences and Similarities. British Journal of Haematology, 174, 203-217. https://doi.org/10.1111/bjh.14147
|
[11]
|
Zhang, K., Jordan, M.B., Marsh, R.A., Johnson, J.A., Kissel, D., Meller, J., et al. (2011) Hypomorphic Mutations in PRF1, MUNC13-4, and STXBP2 Are Associated with Adult Onset Familial HLH. Blood, 118, 5794-5798. https://doi.org/10.1182/blood-2011-07-370148
|
[12]
|
Chen, X., Wang, F., Zhang, Y., Teng, W., Wang, M., Nie, D., et al. (2018) Genetic Variant Spectrum in 265 Chinese Patients with Hemophagocytic Lymphohistiocytosis: Molecular Analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A and XIAP. Clinical Genetics, 94, 200-212. https://doi.org/10.1111/cge.13363
|
[13]
|
Miao, Y., Zhu, H.Y., Qiao, C., Xia, Y., Kong, Y., Zou, Y.X., et al. (2019) Pathogenic Gene Mutations or Variants Identified by Targeted Gene Sequencing in Adults with Hemophagocytic Lymphohistiocytosis. Frontiers in Immunology, 10, Article 395. https://doi.org/10.3389/fimmu.2019.00395
|
[14]
|
Henter, J.I., Horne, A., Aricó, M., et al. (2007) Hlh-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediat Blood Cancer, 48, 124-131. https://doi.org/10.1002/pbc.21039
|
[15]
|
Allen, C.E., Yu, X., Kozinetz, C.A. and McClain, K.L. (2008) Highly Elevated Ferritin Levels and the Diagnosis of Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 50, 1227-1235. https://doi.org/10.1002/pbc.21423
|
[16]
|
噬血细胞综合征中国专家联盟, 中华医学会儿科学分会血液学组. 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98(2): 91-95.
|
[17]
|
Jordan, M.B., Allen, C.E., Greenberg, J., Henry, M., Hermiston, M.L., et al. (2018) Challenges in the Diagnosis of Hemophagocytic Lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatric Blood & Cancer, 66, e27929. https://doi.org/10.1002/pbc.27929
|
[18]
|
Zhang, J.R., Liang, X.L., Jin, R. and Lu, G. (2013) [HLH-2004 Protocol: Diagnostic and Therapeutic Guidelines for Childhood Hemophagocytic Lymphohistiocytosis]. Chinese Journal of Contemporary Pediatrics, 15, 686-688.
|
[19]
|
Hayden, A., Park, S., Giustini, D., Lee, A.Y. and Chen, L.Y. (2016) Hemophagocytic Syndromes (HPSs) Including Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Systematic Scoping Review. Blood Reviews, 30, 411-420. https://doi.org/10.1016/j.blre.2016.05.001
|
[20]
|
Sovinz, P., Schwinger, W., Lackner, H., et al. (2010) Severe Epstein-Barr Virus Encephalitis with Hemophagocytic Syndrome: Rapid Clearance of Virus Following Allogeneic Hematopoietic Stem Cell Transplantation from a Seropositive Donor. The Pediatric Infectious Disease Journal, 29, 553-556. https://doi.org/10.1097/INF.0b013e3181d1de1d
|
[21]
|
Ravelli, A., Davi, S., Minoia, F., et al. (2015) Macrophage Activation Syndrome. Hematology/Oncology Clinics of North America, 29, 927-941. https://doi.org/10.1016/j.hoc.2015.06.010
|
[22]
|
La Rosée, P., Horne, A., Hines, M., et al. (2019) Recommendations for the Management of Hemophagocytic Lymphohistiocytosis in Adults. Blood, 133, 2465-2477. https://doi.org/10.1182/blood.2018894618
|
[23]
|
Janka, G.E. and Lehmberg, K. (2013) Hemophagocytic Lymphohistiocytosis: Pathogenesis 26 and Treatment. Hematology, 2013, 605-611. https://doi.org/10.1182/asheducation-2013.1.605
|
[24]
|
Yildiz, H., Bailly, S., Van Den Neste, E. and Yombi, J.C. (2021) Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Merging Therapies. Therapeutics and Clinical Risk Management, 17, 293-304. https://doi.org/10.2147/TCRM.S195538
|
[25]
|
Felber, M., Steward, C.G., Kentouche, K., et al. (2020) Targeted Busulfanbased Reduced-Intensity Conditioning and HLA-Matched HSCT Cure Hemophagocytic Lymphohistiocytosis. Blood Advances, 4, 1998-2010. https://doi.org/10.1182/bloodadvances.2020001748
|
[26]
|
Lam, M.T., Coppola, S., Krumbach, O.H.F., et al. (2019) A Novel Disorder Involving Dyshematopoiesis, Inflammation, and HLH Due to Aberrant CDC42 Function. Journal of Experimental Medicine, 216, 2778-2799. https://doi.org/10.1084/jem.20190147
|
[27]
|
Schram, A.M. and Berliner, N. (2015) How I Treat Hemophagocytic Lymphohistiocytosis in the 8 Adult Patient. Blood, 125, 2908-2914. https://doi.org/10.1182/blood-2015-01-551622
|